Drug Database
Back to search

Poland· PL-100261329

Intelence

A etravirine product containing etravirinum, registered in Poland by Janssen-Cilag International N.V.. The same ATC class is registered in 14 of our 19 countries.

ATC J05AG04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedIntelenceATCJ05AG04REGISTER NO.PL-100261329PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about etravirinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Etravirine is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AG04 (etravirine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search etravirine products by name

Etravirine · ATC J05AG04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etravirine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $7.80 in France to $15.34 in Switzerland — a ×2.0 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Etravirine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$15.34
  • FR France$7.80
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Etravirinum
Manufacturer
Janssen-Cilag International N.V.
Country
Poland (PL)
ATC code
J05AG04
ATC class
Etravirine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990916382

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

316 interactions on record for etravirine.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check etravirine against other medicinesHow interaction checks work

Etravirine · interactions on record

316 records

  • 33 severe
  • 260 moderate
  • 14 minor

Most severe, free to view

  • DeflazacortH02AB13severe
  • BosutinibL01EA04severe
  • EncorafenibL01EC03severe
  • BrigatinibL01ED04severe

9 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etravirine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etravirine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Intelence
  • Liechtenstein · Intelence
  • Norway · Intelence

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/98f8a072-afe9-4118-bc3a-cff0735ee922
GET /v1/drugs/98f8a072-afe9-4118-bc3a-cff0735ee922?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "200 mg",
  "packaging": "05909990916382 ¦ Rpz ¦ EU/1/08/468/002 ¦ 71009\n60 tabl.",
  "substance": "Etravirinum 200 mg",
  "common_name": "Etravirinum",
  "pl_product_id": "100261329",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about etravirine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console